What companies are 603233.SS's competitors?

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 603233.SS compare to its peers?

The peer comparison table on this page shows DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 603233.SS operate in?

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

SHH·Biotechnology · Healthcare

¥18.69¥0.07−0.37%

Market cap¥21.29B·Market closed·Jul 23 7:00 AM UTC

Frequently Asked Questions About 603233.SS

What companies are 603233.SS's competitors?: DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 603233.SS compare to its peers?: The peer comparison table on this page shows DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 603233.SS operate in?: DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

SHH·Biotechnology · Healthcare

¥18.69¥0.07−0.37%

Market cap¥21.29B·Market closed·Jul 23 7:00 AM UTC

Peers


600511.SS	China National Medicines Corporation Ltd.	¥27.40	¥20.7B
600380.SS	Joincare Pharmaceutical Group Industry Co.,Ltd.	¥10.31	¥18.9B
603658.SS	Autobio Diagnostics Co., Ltd.	¥32.18	¥18.4B
600062.SS	China Resources Double-Crane Pharmaceutical Co.,Ltd.	¥17.11	¥17.8B
600739.SS	Liaoning Cheng Da Co., Ltd.	¥10.91	¥16.6B
300957.SZ	Yunnan Botanee Bio-Technology Group Co.LTD	¥33.18	¥14.0B
300009.SZ	Anhui Anke Biotechnology (Group) Co., Ltd.	¥8.21	¥13.7B
688062.SS	Mabwell (Shanghai) Bioscience Co., Ltd.	¥33.15	¥13.2B
300049.SZ	Inner Mongolia Furui Medical Science Co., Ltd.	¥45.85	¥12.1B
300204.SZ	Staidson (Beijing) BioPharmaceuticals Co., Ltd.	¥24.44	¥11.7B

Frequently Asked Questions About 603233.SS

What companies are 603233.SS's competitors?: DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 603233.SS compare to its peers?: The peer comparison table on this page shows DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 603233.SS operate in?: DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.